Boston Scientific (BSX) Tops Q3 EPS by 1c, Updates Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Wall Street sinks as bond yields rise, Walmart results disappoint
Boston Scientific Announces Results For Third Quarter 2018
October 24, 2018 6:30 AM EDTMARLBOROUGH, Mass., Oct. 24, 2018 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated sales of $2.393 billion during the third quarter ended September 30, 2018. This represents growth of 7.7 percent on a reported basis, 9.1 percent on an operational1 basis and 8.7 percent on an organic2 basis, all compared to the prior year period. The company reported GAAP earnings of $432 million or $0.31 per share (EPS), compared to GAAP earnings of $283 million or $0.20 per share a year ago, and achieved adjusted earnings per share of $0.35 for the period, compared to $0.31 a year ago.
... More